0001127602-24-008499.txt : 20240305
0001127602-24-008499.hdr.sgml : 20240305
20240305160413
ACCESSION NUMBER: 0001127602-24-008499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Timothy Eugene
CENTRAL INDEX KEY: 0001707000
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 24720217
MAIL ADDRESS:
STREET 1: 800 BOYLSTON ST., SUITE 3310
STREET 2: PRUDENTIAL TOWER C/O AJU IB INVESTMENT
CITY: BOSTON
STATE: MA
ZIP: 02199
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-01
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001707000
Sullivan Timothy Eugene
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Chief Financial Officer
1
Common Stock
56232
I
The Timothy E Sullivan Irrevocable Trust of 2023
Common Stock
2024-03-01
4
M
0
6000
10.03
A
99338
D
Common Stock
2024-03-01
4
S
0
4000
62.86
D
95338
D
Common Stock
2024-03-01
4
S
0
2000
63.95
D
93338
D
Stock Option (Right to Buy)
10.03
2024-03-01
4
M
0
6000
0
D
2027-10-18
Common Stock
6000
261903
D
The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
This is a scheduled exercise & sale from 10b5-1 trading plan dated 12/1/23.
This option was granted on October 18, 2017 and fully vested.
/s/s David Watson, attorney-in-fact for Timothy Sullivan
2024-03-05